Evidence generation for wound care dressing selection: reviewing the issues

Area of Science:

• Medical device regulation
• Wound care
• Evidence-based practice

Background:

• UK medical device regulations require limited evidence of effectiveness for wound dressings before clinical use.
• This has resulted in a scarcity of clinical trial data for wound dressing efficacy.
• Governing bodies are prioritizing price over evidence in dressing selection, impacting clinical decisions.

Purpose of the Study:

• To summarize issues in generating evidence for wound dressing selection.
• To critique the current evidence-based practice (EBP) movement in wound care.
• To highlight the implications of resource limitations and legislative constraints on methodological choices.

Main Methods:

• Literature review and critical analysis of current UK policies on wound dressings.
• Examination of the evidence-based practice (EBP) framework in the context of wound care.
• Discussion of the impact of cost-driven purchasing decisions on clinical practice.

Main Results:

• A lack of robust clinical trial evidence for wound dressing effectiveness in the UK.
• The current system prioritizes cost over clinical evidence, potentially compromising wound management.
• Clinicians face challenges due to limited resources, legislative ambiguity, and restricted methodological options.

Conclusions:

• Wound dressings are therapeutic medical devices, not consumables, and cost-based selection is inappropriate.
• Relying on price over evidence may negatively impact clinicians' ability to effectively manage wounds.
• There is a critical need for improved evidence generation and regulatory clarity in wound dressing selection.